ETHINYL ESTRADIOL; SEGESTERONE ACETATE
| Brand name | ANNOVERA |
|---|---|
| Active ingredient | ETHINYL ESTRADIOL; SEGESTERONE ACETATE |
| Strength | 0.013MG/24HR;0.15MG/24HR |
| Dosage form | RING |
| Route | VAGINAL |
| Modality | Small molecule |
| FDA approval | August 2018 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12303518 | June 2039 | product |
| 10918649 | June 2039 | product |
| 10925882 | June 2039 | product |
| 10940157 | June 2039 | product |
| 11850251 | June 2039 | use U-3785 |
| 11529308 | June 2039 | product |
| 10780047 | February 2039 | use U-2786 |
| 10765628 | February 2039 | use U-2787 |
| 10632066 | February 2039 | use U-2786 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.